Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy

الملخص EN

Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures.

Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively.

Recently, however, there is a concern regarding long bone insufficiency fractures related to long-term alendronate therapy.

We report a case of bilateral femoral insufficiency fractures likely related to long-term alendronate therapy, the classic symptoms, signs, and treatment of these fractures.